{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:50:31Z","timestamp":1792273831975,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.semarthrit.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,9,28]],"date-time":"2008-09-28T08:08:15Z","timestamp":1222589295000},"page":"294-312","source":"Crossref","is-referenced-by-count":282,"title":["Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention"],"prefix":"10.1016","volume":"39","author":[{"given":"Harald E.","family":"Vonkeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart A.F.J.","family":"van de Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.08.001_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/gut.2005.065003","article-title":"COX-2 chronology","volume":"54","author":"Hawkey","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/S0002-9343(00)00627-6","article-title":"Nonsteroidal anti-inflammatory drug prescribing: past, present and future","volume":"110","author":"Jones","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(97)07087-6","article-title":"One hundred years of aspirin","volume":"350","author":"Jack","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib5","unstructured":"The Holy Bible, Romans 1:20"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1098\/rstl.1763.0033","article-title":"An account of the success of the bark of the willow in the cure of agues","volume":"53","author":"Stone","year":"1763","journal-title":"Philos Trans R Soc Lond"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib7","series-title":"100 years of Aspirin","year":"1997"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01662127","article-title":"Pharmacologisches uber aspirin (acetylsalicyl-saure)","volume":"76","author":"Dreser","year":"1899","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib12","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(00)78970-7","article-title":"Gastroscopic observation of the effect of aspirin and certain other substances on the stomach","volume":"2","author":"Douthwaite","year":"1938","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib13","first-page":"38","article-title":"Experiences with aspirin (acetylsalicylic acid) in the non-specific prophylaxis of coronary thrombosis","volume":"75","author":"Craven","year":"1953","journal-title":"Mississippi Valley Med J"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(68)92228-9","article-title":"Effects of salicylates on human platelets","volume":"1","author":"O'Brian","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.1.5905.436","article-title":"A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction","volume":"1","author":"Elwood","year":"1974","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/BF01778029","article-title":"Uber die spezifische blutdrucksenkende substanz des menschlichen prostate- und samenblasensekrets","volume":"14","author":"von Euler","year":"1935","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1113\/jphysiol.1935.sp003269","article-title":"Properties of human seminal plasma","volume":"84","author":"Goldblatt","year":"1935","journal-title":"J Physiol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib18","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/S0021-9258(19)76743-X","article-title":"The prostaglandins, Sune Bergstr\u00f6m and Bengt Samuelsson","volume":"281","author":"Kresge","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib19","first-page":"92","article-title":"Sune Bergstrom, biographical memoirs","volume":"151","author":"Hamburg","year":"2007","journal-title":"Proc Am Philos Soc"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/203839a0","article-title":"Enzymatic conversion of ALL-CIS-polyunsaturated fatty acids into prostaglandins","volume":"203","author":"Van Dorp","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0304-4165(64)90144-8","article-title":"The biosynthesis of prostaglandins","volume":"90","author":"Van Dorp","year":"1964","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/newbio231235a0","article-title":"Aspirin selectively inhibits prostaglandin production in human platelets","volume":"231","author":"Smith","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(71)90225-X","article-title":"Effect of aspirin on human seminal prostaglandins","volume":"2","author":"Collier","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib25","first-page":"1193","article-title":"The discovery of brufen","volume":"23","author":"Adams","year":"1987","journal-title":"Chem Br"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.27.5.457","article-title":"Ibuprofen in rheumatoid arthritis","volume":"27","author":"Jasani","year":"1968","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/newbio238104a0","article-title":"Effects of anti-inflammatory drugs on prostaglandin biosynthesis","volume":"238","author":"Flower","year":"1972","journal-title":"Nat New Biol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib28","doi-asserted-by":"crossref","first-page":"16737","DOI":"10.1016\/S0021-9258(17)44821-6","article-title":"The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes","volume":"265","author":"Fu","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"The structure of human cyclooxygenase2, conservation and flexibility of the NSAID binding size","volume":"3","author":"Luong","year":"1996","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"Cox-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/bi971691n","article-title":"Investigation of the binding of isoform-selective inhibitors to prostaglandin endoperoxide synthases using fluorescence spectroscopy","volume":"37","author":"Lanzo","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib33","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/S0002-9343(00)00629-X","article-title":"Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem","volume":"110","author":"Brun","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","article-title":"Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Langman","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5414\/CPP45281","article-title":"Under-utilization of gastroprotective drugs in patients with NSAID-related ulcers","volume":"45","author":"Vonkeman","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Int Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib37","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1572-0241.1998.00588.x","article-title":"A guideline for the treatment and prevention of NSAID-induced ulcers","volume":"93","author":"Lanza","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 51","key":"10.1016\/j.semarthrit.2008.08.001_bib38","first-page":"8","article-title":"NSAID-induced gastrointestinal complications: the ARAMIS perspective\u20141997","volume":"25","author":"Singh","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/ard.2003.015925","article-title":"Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach","volume":"63","author":"Richy","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib40","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"i","author":"Warren","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib41","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"i","author":"Marshall","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","article-title":"Attempt to fulfill Koch's postulates for pyloric campylobacter","volume":"142","author":"Marshall","year":"1985","journal-title":"Med J Aust"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cgh.2005.10.006","article-title":"Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review","volume":"4","author":"Papatheodoridis","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9343(97)00209-X","article-title":"Does Helicobacter pylori status affect nonsteroidal anti-inflammatory drug-associated gastroduodenal pathology?","volume":"104","author":"Malfertheiner","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/gut.51.3.329","article-title":"Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial","volume":"51","author":"Labenz","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1523-5378.2007.00543.x","article-title":"Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID-treatment: double-blind, randomized, placebo-controlled trial","volume":"12","author":"de Leest","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib51","first-page":"207","article-title":"Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract","volume":"2","author":"Hirschowitz","year":"1994","journal-title":"Gastroenterologist"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration","volume":"28","author":"Armstrong","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00002512-200724080-00005","article-title":"Direct medical costs of serious gastrointestinal ulcers among users of non steroidal anti-inflammatory drugs","volume":"24","author":"Vonkeman","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-123-5-199509010-00004","article-title":"Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens","volume":"123","author":"Raskin","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2008.08.001_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archinte.159.7.649","article-title":"Importance of pH control in the management of GERD","volume":"159","author":"Hunt","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2008.08.001_bib58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1590-8658(00)80821-X","article-title":"Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study","volume":"32","author":"Bianchi Porro","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib59","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","article-title":"The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review","volume":"329","author":"Hooper","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1365-2036.2006.02867.x","article-title":"Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole","volume":"23","author":"Goldstein","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib61","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1572-0241.2006.00686.x","article-title":"Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole","volume":"101","author":"Regula","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib62","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1001\/archinte.156.20.2321","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury","volume":"156","author":"Koch","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib63","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","article-title":"Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs","volume":"334","author":"Taha","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib64","first-page":"663","article-title":"Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients","volume":"92","author":"Bianchi Porro","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib65","first-page":"223","article-title":"Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study","volume":"91","author":"Raskin","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib66","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs","volume":"338","author":"Yeomans","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib68","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib69","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0","article-title":"Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip","volume":"43","author":"Cannon","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib70","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/41.9.1008","article-title":"Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: a randomized, controlled comparison with placebo and naproxen","volume":"41","author":"Bensen","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib71","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4065\/80.4.470","article-title":"Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"80","author":"Wiesenhutter","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib72","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib73","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib74","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(07)60234-7","article-title":"Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"369","author":"Laine","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial","volume":"364","author":"Schnitzer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0016-5085(99)70545-7","article-title":"Effect of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans","volume":"117","author":"Cryer","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib77","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.1998.00312.x","article-title":"Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer","volume":"12","author":"Bianchi Porro","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib80","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib81","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib82","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2004.07.010","article-title":"Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial","volume":"127","author":"Chan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib83","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.amjmed.2005.04.031","article-title":"Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications","volume":"118","author":"Lai","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib84","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib85","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib86","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib87","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib89","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2005.08.097","article-title":"Colorectal cancer prevention","volume":"23","author":"Hawk","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib90","author":"Chan"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib91","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","article-title":"The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S","volume":"146","author":"Dube","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib92","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S","volume":"146","author":"Rostom","year":"2007","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1016\/j.semarthrit.2008.08.001_bib93","doi-asserted-by":"crossref","first-page":"D26","DOI":"10.1016\/S0002-9149(02)02234-8","article-title":"Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations","volume":"89","author":"FitzGerald","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib94","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.332.7546.895","article-title":"Understanding the NSAID related risk of vascular events","volume":"332","author":"Vonkeman","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib95","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.93.19.10417","article-title":"Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress","volume":"93","author":"Topper","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib96","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib97","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib98","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib99","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)16894-3","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial","volume":"364","author":"Farkouh","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib100","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","article-title":"Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"368","author":"Cannon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib101","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib102","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis?","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.068650","article-title":"Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials","author":"Scott","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib105","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effect of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib106","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"Capone","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib107","author":"Solomon"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib108","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib109","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(03)12560-3","article-title":"Parsing an enigma: the pharmacodynamics of aspirin resistance","volume":"361","author":"Fitzgerald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study","volume":"162","author":"Feenstra","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib111","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem","volume":"160","author":"Page","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib112","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(04)16299-5","article-title":"Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study","volume":"363","author":"Mamdani","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib113","author":"Kaplan"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib114","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archinte.165.5.ioi50013","article-title":"Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure","volume":"165","author":"Aw","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib115","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/archinte.162.19.2204","article-title":"Frequency of analgesic use and risk of hypertension in younger women","volume":"162","author":"Curhan","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib116","author":"Rose"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib117","first-page":"192","article-title":"Clinical physiology of acid-base and electrolyte disorders","author":"Rose","year":"2001"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib118","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwj331","article-title":"Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis","volume":"164","author":"Schneider","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-133-1-200007040-00002","article-title":"Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet","volume":"133","author":"Swan","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/scientificamerican0107-84","article-title":"Better ways to target pain","volume":"296","author":"Stix","year":"2007","journal-title":"Sci Am"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib122","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tips.2006.06.001","article-title":"Is mPGES-1 a promising target for pain therapy?","volume":"27","author":"Scholich","year":"2006","journal-title":"Trends Pharm Sci"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib123","first-page":"1569","article-title":"Pain relief in osteoarthritis: patients' willingness to risk medication-induced gastrointestinal, cardiovascular, and cerebrovascular complications","volume":"34","author":"Richardson","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.001_bib124","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ncpgasthep0610","article-title":"Primer: managing NSAID-induced ulcer complications\u2014balancing gastrointestinal and cardiovascular risks","volume":"3","author":"Chan","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T11:51:26Z","timestamp":1631879486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0049017208001339"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.08.001","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}